Edesa Biotech, Inc. (EDSA) stock
EDSANasdaqPharmaceutical PreparationsFiscal year ends September 30
$1.89−0.05 (-2.58%)
Close on Nov 16, 2026Market cap $18.22MP/E –Yield –
Edesa Biotech enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Edesa Biotech's enterprise value was $11.09M on Nov 11, 2026, against $1.71M a year earlier. Over the last 5 years it ranged from -$2.44M to $516.12M, with a median of $14.46M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $11.09M | – |
| 2025 | Dec 31, 2025 | -$650.84K | -114.7% |
| 2024 | Dec 31, 2024 | $4.42M | -49.2% |
| 2023 | Dec 29, 2023 | $8.69M | -69.9% |
| 2022 | Dec 30, 2022 | $28.90M | -94.4% |
| 2021 | Dec 31, 2021 | $516.12M | +85.1% |
| 2020 | Dec 31, 2020 | $278.83M | +32.6% |
| 2019 | Dec 31, 2019 | $210.34M | +8.5% |
| 2018 | Dec 31, 2018 | $193.92M | -44.8% |
| 2017 | Dec 29, 2017 | $351.35M | -58.8% |
| 2016 | Dec 30, 2016 | $852.76M | -59.8% |
| 2015 | Dec 31, 2015 | $2.12B | -44.2% |
| 2014 | Dec 31, 2014 | $3.80B | -11.1% |
| 2013 | Dec 31, 2013 | $4.28B | +703.4% |
| 2012 | Dec 31, 2012 | $532.19M | – |
See a number that looks wrong?